Approvals/TGA/CALQUENCE acalabrutinib (as maleate) 100 mg film-coated tablet blister pack

Approved

STANDARD

CALQUENCE acalabrutinib (as maleate) 100 mg film-coated tablet blister pack

AstraZeneca Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ff597aed73dee3eb
Product Name: CALQUENCE acalabrutinib (as maleate) 100 mg film-coated tablet blister pack
Artg Id: 377410
Artg Name: CALQUENCE acalabrutinib (as maleate) 100 mg film-coated tablet blister pack
Sponsor: AstraZeneca Pty Ltd
Company Detail Path: /organization/astrazeneca-pty-ltd
Artg Date: 2022-10-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REPI
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01611-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-02150-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ff597aed73dee3eb

Type

Standard